Schimmel Paul

DirectoraTYR PHARMA INC (ATYR) · full profile →Form 4 · filed Jul 24, 2024
Net Buying
Open-Market Buys
$184K
Open-Market Sells
$0
Net Open-Market Flow
$184K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 24, 2024Buy(P)52K$1.93$101K413K
Jul 23, 2024Buy(P)7K$1.82$12K361K
Jul 22, 2024Buy(P)41K$1.74$71K354K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-086159) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ATYR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-086159"
Ask your agent
Use Arkolith to summarize insider buying and selling at aTYR PHARMA INC
over the last 90 days and cite the filings.